Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Angioplasty, Balloon, Coronary | 39 | 2013 | 1721 | 1.650 |
Why?
|
Drug-Eluting Stents | 19 | 2015 | 680 | 0.920 |
Why?
|
Osteoarthritis, Knee | 10 | 2023 | 1251 | 0.800 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 14 | 2016 | 325 | 0.720 |
Why?
|
Stents | 20 | 2015 | 3193 | 0.560 |
Why?
|
Registries | 38 | 2016 | 8351 | 0.480 |
Why?
|
Arthroplasty, Replacement, Knee | 7 | 2023 | 1389 | 0.470 |
Why?
|
Obesity, Morbid | 6 | 2023 | 1292 | 0.410 |
Why?
|
Coronary Artery Disease | 20 | 2016 | 6558 | 0.410 |
Why?
|
Bariatric Surgery | 6 | 2021 | 996 | 0.380 |
Why?
|
Coronary Disease | 14 | 2012 | 5915 | 0.370 |
Why?
|
Gastric Bypass | 4 | 2023 | 820 | 0.350 |
Why?
|
Pain Measurement | 5 | 2024 | 3576 | 0.290 |
Why?
|
Myocardial Infarction | 25 | 2016 | 11513 | 0.280 |
Why?
|
Exercise Therapy | 3 | 2019 | 938 | 0.280 |
Why?
|
Myocardial Revascularization | 6 | 2012 | 795 | 0.280 |
Why?
|
Menopause | 7 | 2016 | 1657 | 0.250 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2009 | 2160 | 0.250 |
Why?
|
Carotid Artery Diseases | 3 | 2014 | 872 | 0.240 |
Why?
|
Catastrophization | 2 | 2020 | 352 | 0.230 |
Why?
|
Coronary Vessels | 5 | 2014 | 3100 | 0.220 |
Why?
|
Spondylarthritis | 1 | 2024 | 62 | 0.210 |
Why?
|
Diabetes Complications | 6 | 2021 | 1319 | 0.200 |
Why?
|
Spondylitis, Ankylosing | 1 | 2024 | 158 | 0.200 |
Why?
|
Tibial Fractures | 1 | 2025 | 276 | 0.190 |
Why?
|
Women's Health | 4 | 2016 | 2081 | 0.190 |
Why?
|
Vasomotor System | 2 | 2012 | 208 | 0.180 |
Why?
|
Hot Flashes | 3 | 2012 | 329 | 0.180 |
Why?
|
Coronary Restenosis | 7 | 2013 | 396 | 0.180 |
Why?
|
Treatment Outcome | 42 | 2025 | 65273 | 0.170 |
Why?
|
Preoperative Period | 3 | 2020 | 564 | 0.170 |
Why?
|
Uveitis | 1 | 2024 | 398 | 0.170 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2019 | 44 | 0.170 |
Why?
|
Middle Aged | 73 | 2025 | 223257 | 0.160 |
Why?
|
Metals | 6 | 2015 | 712 | 0.160 |
Why?
|
Diabetes Mellitus | 8 | 2021 | 5887 | 0.160 |
Why?
|
Laparoscopy | 3 | 2022 | 2039 | 0.160 |
Why?
|
Frail Elderly | 1 | 2024 | 781 | 0.160 |
Why?
|
Coronary Stenosis | 3 | 2011 | 803 | 0.150 |
Why?
|
Knee Injuries | 1 | 2023 | 495 | 0.150 |
Why?
|
Clubfoot | 1 | 2019 | 87 | 0.150 |
Why?
|
Aged | 59 | 2025 | 171343 | 0.150 |
Why?
|
Fracture Fixation, Internal | 1 | 2025 | 982 | 0.150 |
Why?
|
Musculoskeletal Diseases | 1 | 2024 | 598 | 0.150 |
Why?
|
Coronary Angiography | 13 | 2014 | 4508 | 0.150 |
Why?
|
Aortic Diseases | 1 | 2004 | 741 | 0.150 |
Why?
|
Female | 87 | 2025 | 396520 | 0.140 |
Why?
|
Geriatric Assessment | 1 | 2024 | 1422 | 0.130 |
Why?
|
United States | 39 | 2021 | 72951 | 0.130 |
Why?
|
Hip Fractures | 1 | 2024 | 996 | 0.130 |
Why?
|
Weight Loss | 4 | 2023 | 2712 | 0.130 |
Why?
|
Follicle Stimulating Hormone | 2 | 2015 | 731 | 0.130 |
Why?
|
Male | 75 | 2025 | 364142 | 0.130 |
Why?
|
Risk Factors | 33 | 2024 | 74881 | 0.130 |
Why?
|
Disability Evaluation | 2 | 2024 | 1827 | 0.120 |
Why?
|
Renal Insufficiency | 2 | 2016 | 811 | 0.120 |
Why?
|
Carotid Arteries | 2 | 2014 | 932 | 0.120 |
Why?
|
Follow-Up Studies | 22 | 2021 | 39309 | 0.120 |
Why?
|
Humans | 98 | 2025 | 766766 | 0.120 |
Why?
|
Gastroplasty | 2 | 2016 | 153 | 0.120 |
Why?
|
Orthopedic Procedures | 1 | 2024 | 1279 | 0.110 |
Why?
|
Angina, Unstable | 2 | 2009 | 893 | 0.110 |
Why?
|
Pain, Postoperative | 2 | 2024 | 1768 | 0.110 |
Why?
|
Prescriptions | 1 | 2016 | 388 | 0.110 |
Why?
|
Osteoarthritis | 1 | 2021 | 1072 | 0.110 |
Why?
|
Aorta | 1 | 2001 | 2043 | 0.110 |
Why?
|
Hospital Mortality | 13 | 2012 | 5343 | 0.110 |
Why?
|
Cardiovascular Agents | 3 | 2016 | 849 | 0.100 |
Why?
|
Compression Bandages | 1 | 2012 | 14 | 0.100 |
Why?
|
Hemorrhage | 2 | 2016 | 3464 | 0.100 |
Why?
|
Prosthesis Design | 7 | 2014 | 2120 | 0.100 |
Why?
|
Coronary Circulation | 2 | 2010 | 1602 | 0.100 |
Why?
|
Proportional Hazards Models | 13 | 2013 | 12534 | 0.100 |
Why?
|
Range of Motion, Articular | 1 | 2018 | 1597 | 0.100 |
Why?
|
Arthralgia | 1 | 2015 | 459 | 0.090 |
Why?
|
Retreatment | 5 | 2011 | 598 | 0.090 |
Why?
|
Prospective Studies | 21 | 2020 | 54871 | 0.090 |
Why?
|
Vascular Diseases | 2 | 2013 | 1161 | 0.090 |
Why?
|
Coronary Aneurysm | 1 | 2013 | 234 | 0.090 |
Why?
|
Blood Flow Velocity | 3 | 2005 | 1374 | 0.090 |
Why?
|
Time Factors | 19 | 2016 | 40149 | 0.090 |
Why?
|
Coronary Artery Bypass | 9 | 2011 | 2188 | 0.090 |
Why?
|
Binge-Eating Disorder | 1 | 2012 | 156 | 0.090 |
Why?
|
Academies and Institutes | 1 | 2012 | 326 | 0.080 |
Why?
|
Drug Utilization | 1 | 2016 | 1187 | 0.080 |
Why?
|
Age Factors | 11 | 2024 | 18397 | 0.080 |
Why?
|
Chi-Square Distribution | 6 | 2012 | 3432 | 0.080 |
Why?
|
Consensus | 1 | 2019 | 3208 | 0.080 |
Why?
|
Patient Compliance | 2 | 2018 | 2694 | 0.080 |
Why?
|
Exercise Tolerance | 1 | 2014 | 847 | 0.080 |
Why?
|
Telemetry | 1 | 2010 | 201 | 0.080 |
Why?
|
beta 2-Glycoprotein I | 1 | 2009 | 28 | 0.080 |
Why?
|
Pain | 3 | 2023 | 5098 | 0.080 |
Why?
|
Comorbidity | 9 | 2018 | 10580 | 0.080 |
Why?
|
Hemostasis | 1 | 2011 | 467 | 0.080 |
Why?
|
Prescription Drugs | 1 | 2016 | 634 | 0.080 |
Why?
|
Diabetic Angiopathies | 2 | 2011 | 806 | 0.080 |
Why?
|
Patient Discharge | 2 | 2016 | 3465 | 0.080 |
Why?
|
Motor Activity | 1 | 2018 | 2711 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2016 | 2763 | 0.070 |
Why?
|
Obesity | 5 | 2023 | 13090 | 0.070 |
Why?
|
After-Hours Care | 1 | 2008 | 102 | 0.070 |
Why?
|
Gastrectomy | 2 | 2023 | 693 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 488 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3692 | 0.070 |
Why?
|
Sex Factors | 7 | 2011 | 10619 | 0.070 |
Why?
|
Lipoproteins | 1 | 2012 | 871 | 0.070 |
Why?
|
Tunica Intima | 2 | 2013 | 455 | 0.070 |
Why?
|
Severity of Illness Index | 9 | 2020 | 15908 | 0.070 |
Why?
|
Arteriosclerosis | 2 | 2004 | 1055 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2429 | 0.070 |
Why?
|
Survival Rate | 9 | 2013 | 12825 | 0.070 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2010 | 399 | 0.070 |
Why?
|
Sweating | 3 | 2012 | 155 | 0.070 |
Why?
|
Computer Systems | 1 | 2008 | 467 | 0.070 |
Why?
|
Arterial Occlusive Diseases | 1 | 2011 | 742 | 0.070 |
Why?
|
Kidney Failure, Chronic | 2 | 2011 | 2505 | 0.070 |
Why?
|
Iliac Aneurysm | 1 | 2006 | 37 | 0.070 |
Why?
|
Insulin | 3 | 2012 | 6608 | 0.060 |
Why?
|
Risk Assessment | 10 | 2016 | 24295 | 0.060 |
Why?
|
Blood Transfusion | 2 | 2016 | 1308 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 6 | 2013 | 6512 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2006 | 1456 | 0.060 |
Why?
|
Retrospective Studies | 17 | 2025 | 81635 | 0.060 |
Why?
|
Osteoporotic Fractures | 1 | 2010 | 415 | 0.060 |
Why?
|
Adult | 20 | 2025 | 223307 | 0.060 |
Why?
|
Monitoring, Ambulatory | 1 | 2008 | 357 | 0.060 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2011 | 562 | 0.060 |
Why?
|
Cause of Death | 3 | 2011 | 3716 | 0.060 |
Why?
|
Telephone | 1 | 2008 | 629 | 0.060 |
Why?
|
Creatinine | 2 | 2007 | 1917 | 0.060 |
Why?
|
Heart Failure | 4 | 2011 | 11882 | 0.060 |
Why?
|
Patient Readmission | 2 | 2024 | 3283 | 0.060 |
Why?
|
Thrombosis | 3 | 2013 | 2953 | 0.060 |
Why?
|
Recurrence | 5 | 2019 | 8507 | 0.060 |
Why?
|
Health Behavior | 1 | 2016 | 2649 | 0.060 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2005 | 198 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4252 | 0.060 |
Why?
|
Longitudinal Studies | 6 | 2021 | 14762 | 0.060 |
Why?
|
Collateral Circulation | 1 | 2005 | 289 | 0.060 |
Why?
|
Triglycerides | 1 | 2012 | 2441 | 0.060 |
Why?
|
Aorta, Abdominal | 1 | 2007 | 627 | 0.060 |
Why?
|
Fibrinogen | 2 | 2011 | 893 | 0.050 |
Why?
|
Embolism | 1 | 2007 | 401 | 0.050 |
Why?
|
Remission Induction | 2 | 2021 | 2413 | 0.050 |
Why?
|
Pulsatile Flow | 1 | 2004 | 318 | 0.050 |
Why?
|
Angina Pectoris | 1 | 2006 | 956 | 0.050 |
Why?
|
Death, Sudden, Cardiac | 1 | 2011 | 1567 | 0.050 |
Why?
|
Carotid Artery, Internal | 1 | 2005 | 440 | 0.050 |
Why?
|
Hematoma | 1 | 2007 | 766 | 0.050 |
Why?
|
Quality of Life | 4 | 2019 | 13476 | 0.050 |
Why?
|
Calcinosis | 1 | 2011 | 1480 | 0.050 |
Why?
|
Cohort Studies | 9 | 2024 | 41710 | 0.050 |
Why?
|
Carotid Stenosis | 2 | 2009 | 858 | 0.050 |
Why?
|
Graft Occlusion, Vascular | 1 | 2005 | 538 | 0.050 |
Why?
|
Stroke Volume | 4 | 2011 | 5618 | 0.050 |
Why?
|
Blood Glucose | 3 | 2012 | 6422 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5945 | 0.050 |
Why?
|
Myocardial Ischemia | 2 | 2009 | 2132 | 0.050 |
Why?
|
Mental Health | 1 | 2015 | 3270 | 0.050 |
Why?
|
Minority Groups | 1 | 2008 | 1208 | 0.050 |
Why?
|
Linear Models | 3 | 2019 | 5874 | 0.050 |
Why?
|
Immunosuppressive Agents | 3 | 2012 | 4215 | 0.040 |
Why?
|
Estradiol | 3 | 2012 | 1947 | 0.040 |
Why?
|
Medical Errors | 1 | 2008 | 1260 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2885 | 0.040 |
Why?
|
Aged, 80 and over | 10 | 2024 | 59550 | 0.040 |
Why?
|
Postoperative Period | 2 | 2020 | 1824 | 0.040 |
Why?
|
Blood Vessel Prosthesis | 1 | 2005 | 956 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 454 | 0.040 |
Why?
|
Physical Therapy Modalities | 1 | 2023 | 533 | 0.040 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2846 | 0.040 |
Why?
|
Inpatients | 2 | 2009 | 2565 | 0.040 |
Why?
|
Back Pain | 1 | 2024 | 547 | 0.040 |
Why?
|
Risk Adjustment | 1 | 2003 | 597 | 0.040 |
Why?
|
Tomography, Optical Coherence | 1 | 2013 | 2937 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5536 | 0.040 |
Why?
|
Postoperative Complications | 6 | 2013 | 15831 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2015 | 3420 | 0.040 |
Why?
|
Incidence | 7 | 2013 | 21525 | 0.040 |
Why?
|
Odds Ratio | 5 | 2016 | 9661 | 0.040 |
Why?
|
Venous Thromboembolism | 1 | 2012 | 1882 | 0.040 |
Why?
|
Heart Transplantation | 1 | 2013 | 3306 | 0.040 |
Why?
|
Musculoskeletal Manipulations | 1 | 2018 | 24 | 0.040 |
Why?
|
Elasticity | 1 | 2001 | 654 | 0.040 |
Why?
|
Tenotomy | 1 | 2019 | 53 | 0.040 |
Why?
|
Hypoglycemic Agents | 2 | 2009 | 3108 | 0.040 |
Why?
|
Benchmarking | 1 | 2005 | 1056 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2012 | 3989 | 0.040 |
Why?
|
Braces | 1 | 2019 | 139 | 0.040 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2011 | 1897 | 0.040 |
Why?
|
Serum Albumin | 1 | 2001 | 675 | 0.040 |
Why?
|
Casts, Surgical | 1 | 2019 | 184 | 0.040 |
Why?
|
Multicenter Studies as Topic | 2 | 2018 | 1733 | 0.040 |
Why?
|
Reoperation | 2 | 2025 | 4325 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5789 | 0.040 |
Why?
|
Models, Cardiovascular | 1 | 2003 | 978 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2008 | 2593 | 0.030 |
Why?
|
Haiti | 1 | 2019 | 553 | 0.030 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2007 | 1251 | 0.030 |
Why?
|
Coronary Thrombosis | 2 | 2011 | 440 | 0.030 |
Why?
|
Kidney | 2 | 2016 | 7074 | 0.030 |
Why?
|
Femoral Artery | 1 | 2001 | 827 | 0.030 |
Why?
|
Anticoagulants | 1 | 2012 | 4855 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8731 | 0.030 |
Why?
|
Czech Republic | 1 | 2016 | 75 | 0.030 |
Why?
|
Resistance Training | 1 | 2018 | 197 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3246 | 0.030 |
Why?
|
Angioplasty | 2 | 2010 | 354 | 0.030 |
Why?
|
Efficiency | 1 | 2019 | 479 | 0.030 |
Why?
|
Canada | 2 | 2016 | 2126 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2783 | 0.030 |
Why?
|
Length of Stay | 4 | 2012 | 6490 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2016 | 507 | 0.030 |
Why?
|
Life Tables | 2 | 2006 | 367 | 0.030 |
Why?
|
Smoking | 3 | 2011 | 9077 | 0.030 |
Why?
|
C-Reactive Protein | 2 | 2011 | 3853 | 0.030 |
Why?
|
Prognosis | 5 | 2018 | 29948 | 0.030 |
Why?
|
Glomerular Filtration Rate | 2 | 2016 | 2232 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 3250 | 0.030 |
Why?
|
C-Peptide | 1 | 2016 | 443 | 0.030 |
Why?
|
Health Services Accessibility | 2 | 2009 | 5514 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2010 | 1241 | 0.030 |
Why?
|
Contrast Media | 1 | 2007 | 5329 | 0.030 |
Why?
|
Electrocardiography | 1 | 2007 | 6408 | 0.030 |
Why?
|
Guideline Adherence | 2 | 2018 | 2234 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2010 | 7868 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2012 | 10745 | 0.030 |
Why?
|
Recovery of Function | 1 | 2024 | 2976 | 0.030 |
Why?
|
Predictive Value of Tests | 5 | 2012 | 15416 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2011 | 12064 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2010 | 1514 | 0.030 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2334 | 0.030 |
Why?
|
Hematopoietic Cell Growth Factors | 1 | 1993 | 98 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2012 | 8540 | 0.030 |
Why?
|
Tunica Media | 1 | 2013 | 107 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2010 | 16044 | 0.030 |
Why?
|
Clinical Competence | 1 | 2008 | 4858 | 0.030 |
Why?
|
Follicle Stimulating Hormone, Human | 1 | 2012 | 25 | 0.030 |
Why?
|
Radiation-Protective Agents | 1 | 1993 | 87 | 0.030 |
Why?
|
Renal Dialysis | 2 | 2016 | 1790 | 0.030 |
Why?
|
Age Distribution | 2 | 2011 | 2869 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 12245 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10384 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10860 | 0.020 |
Why?
|
Regression Analysis | 1 | 2001 | 6329 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2021 | 2693 | 0.020 |
Why?
|
Body Mass Index | 3 | 2018 | 13050 | 0.020 |
Why?
|
Factor VII | 1 | 2011 | 139 | 0.020 |
Why?
|
Logistic Models | 3 | 2016 | 13278 | 0.020 |
Why?
|
Reward | 1 | 2018 | 980 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2012 | 6307 | 0.020 |
Why?
|
Atherectomy, Coronary | 1 | 2011 | 137 | 0.020 |
Why?
|
Hospitalization | 5 | 2009 | 10823 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2010 | 18075 | 0.020 |
Why?
|
Risk | 3 | 2011 | 9602 | 0.020 |
Why?
|
Angiography | 2 | 2006 | 1595 | 0.020 |
Why?
|
Hyperplasia | 1 | 2013 | 1150 | 0.020 |
Why?
|
Aspirin | 2 | 2012 | 3135 | 0.020 |
Why?
|
Arthroscopy | 1 | 2016 | 971 | 0.020 |
Why?
|
Interleukin-1 | 1 | 1993 | 1251 | 0.020 |
Why?
|
Insulin, Long-Acting | 1 | 2009 | 59 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2010 | 527 | 0.020 |
Why?
|
Models, Statistical | 1 | 2003 | 5091 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2012 | 616 | 0.020 |
Why?
|
Research Design | 2 | 2019 | 6207 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2009 | 294 | 0.020 |
Why?
|
Patient Care Team | 1 | 2019 | 2519 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2012 | 642 | 0.020 |
Why?
|
Nitrates | 1 | 2009 | 260 | 0.020 |
Why?
|
Motivation | 1 | 2018 | 2020 | 0.020 |
Why?
|
Ticlopidine | 1 | 2012 | 730 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7431 | 0.020 |
Why?
|
Preoperative Care | 1 | 2016 | 2253 | 0.020 |
Why?
|
Saphenous Vein | 1 | 2010 | 519 | 0.020 |
Why?
|
Product Labeling | 1 | 2008 | 75 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 2012 | 880 | 0.020 |
Why?
|
Algorithms | 1 | 2007 | 14072 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1663 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15657 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2009 | 687 | 0.020 |
Why?
|
Observation | 1 | 2008 | 310 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2011 | 1164 | 0.020 |
Why?
|
North America | 1 | 2009 | 1287 | 0.020 |
Why?
|
Mood Disorders | 1 | 2012 | 1127 | 0.020 |
Why?
|
Sirolimus | 1 | 2012 | 1540 | 0.020 |
Why?
|
Hospital Records | 1 | 2005 | 93 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2016 | 2645 | 0.020 |
Why?
|
Lupus Nephritis | 1 | 2009 | 324 | 0.020 |
Why?
|
Paclitaxel | 1 | 2012 | 1727 | 0.020 |
Why?
|
Prevalence | 2 | 2013 | 15835 | 0.020 |
Why?
|
Hypolipidemic Agents | 1 | 2009 | 609 | 0.020 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2008 | 497 | 0.010 |
Why?
|
Iliac Artery | 1 | 2006 | 344 | 0.010 |
Why?
|
Coronary Occlusion | 1 | 2007 | 284 | 0.010 |
Why?
|
Survival Analysis | 2 | 2008 | 10100 | 0.010 |
Why?
|
Affect | 1 | 2012 | 1494 | 0.010 |
Why?
|
Polysomnography | 1 | 2011 | 1868 | 0.010 |
Why?
|
Cost of Illness | 1 | 2013 | 1949 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9346 | 0.010 |
Why?
|
Hip Joint | 1 | 2010 | 1017 | 0.010 |
Why?
|
Area Under Curve | 1 | 2007 | 1638 | 0.010 |
Why?
|
Vascular Patency | 1 | 2006 | 915 | 0.010 |
Why?
|
Reproducibility of Results | 3 | 2007 | 20144 | 0.010 |
Why?
|
Primary Health Care | 2 | 2010 | 4735 | 0.010 |
Why?
|
Propensity Score | 1 | 2011 | 1972 | 0.010 |
Why?
|
Workload | 1 | 2008 | 849 | 0.010 |
Why?
|
Venous Thrombosis | 1 | 2012 | 1321 | 0.010 |
Why?
|
Haplotypes | 1 | 2009 | 2727 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7841 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2010 | 1895 | 0.010 |
Why?
|
Collagen | 1 | 2010 | 2635 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3430 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2005 | 792 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3624 | 0.010 |
Why?
|
Home Care Services | 1 | 2008 | 659 | 0.010 |
Why?
|
Hypoglycemia | 1 | 2009 | 896 | 0.010 |
Why?
|
Shock, Cardiogenic | 1 | 2007 | 709 | 0.010 |
Why?
|
Fatigue | 1 | 2008 | 1555 | 0.010 |
Why?
|
Homeostasis | 1 | 2012 | 3342 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5306 | 0.010 |
Why?
|
Brachytherapy | 1 | 2008 | 1220 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2746 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 2012 | 2744 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2010 | 1878 | 0.010 |
Why?
|
Blood Pressure | 2 | 2011 | 8533 | 0.010 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 577 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4114 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2009 | 1389 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 2007 | 1479 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6012 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2005 | 1208 | 0.010 |
Why?
|
Incidental Findings | 1 | 2004 | 698 | 0.010 |
Why?
|
Disease Management | 1 | 2010 | 2533 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6895 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2012 | 2596 | 0.010 |
Why?
|
Equipment Design | 1 | 2007 | 3487 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26389 | 0.010 |
Why?
|
Sex Distribution | 1 | 2003 | 2274 | 0.010 |
Why?
|
Echocardiography | 1 | 2011 | 5037 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2007 | 2078 | 0.010 |
Why?
|
Bone Density | 1 | 2010 | 3491 | 0.010 |
Why?
|
Medical Records | 1 | 2002 | 1408 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2351 | 0.010 |
Why?
|
Lung Diseases | 1 | 2007 | 1941 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36461 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2006 | 1403 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2007 | 2101 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42577 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1993 | 9244 | 0.010 |
Why?
|
Genetic Testing | 1 | 2009 | 3591 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2210 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3927 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 2003 | 2053 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4056 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2007 | 20708 | 0.010 |
Why?
|
Stem Cell Factor | 1 | 1993 | 194 | 0.010 |
Why?
|
Medicare | 1 | 2010 | 6820 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 1993 | 260 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9357 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1993 | 877 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2009 | 22248 | 0.010 |
Why?
|
Phenotype | 1 | 2009 | 16724 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1993 | 1767 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14652 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 1999 | 1885 | 0.010 |
Why?
|
Cholesterol | 1 | 1999 | 2903 | 0.010 |
Why?
|
Hypertension | 1 | 2008 | 8616 | 0.000 |
Why?
|
Disease Progression | 1 | 2004 | 13640 | 0.000 |
Why?
|
Lipopolysaccharides | 1 | 1993 | 2214 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1993 | 6507 | 0.000 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1993 | 4349 | 0.000 |
Why?
|
Neoplasms | 1 | 2009 | 22350 | 0.000 |
Why?
|
Mice | 1 | 1993 | 81889 | 0.000 |
Why?
|
Animals | 1 | 1993 | 168930 | 0.000 |
Why?
|